Amorolfine C₂₁H₃₅NO

Therapeutic indications

Amorolfine is indicated for:

Onychomycoses caused by dermatophytes, yeasts, moulds

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Amorolfine is indicated for onychomycoses caused by dermatophytes, yeasts and moulds.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.